Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Galati G, Germanova O. Mineralocorticoid receptor antagonists in end-stage renal disease under renal replacement therapies: bridging the gap between cardiovascular and systemic benefit, from heart failure to myocardial infarction. J Cardiovasc Pharmacol 2025 Feb 6. doi: 10.1097/FJC.0000000000001677.
PMID: 39913314


Privacy Policy